Provided by Tiger Fintech (Singapore) Pte. Ltd.

Maravai LifeSciences Holdings, Inc.

2.01
-0.0350-1.71%
Post-market: 2.010.00000.00%16:20 EDT
Volume:1.28M
Turnover:2.59M
Market Cap:289.36M
PE:-1.91
High:2.12
Open:2.03
Low:1.99
Close:2.05
Loading ...

Maravai Lifesciences Postpones Q4 Earnings Release; Shares Fall

MT Newswires Live
·
25 Feb

Maravai Lifesciences Has Postponed Its Q4 Earnings Release And Call Scheduled For February 25, Maravai Intends To Hold Its Postponed Earnings Call And To File The 2024 Form 10K On Or Before March 18, 2025

Benzinga
·
25 Feb

Maravai Lifesciences postpones Q4, FY24 earnings release, conference call

TIPRANKS
·
25 Feb

Maravai LifeSciences Holdings: Co Still Expects to Be Near Mid-Point of Previously Announced Guidance Range of $255.0 Mln and $265.0 Mln for 2024

THOMSON REUTERS
·
25 Feb

Stock Track | Maravai LifeSciences Plunges 5.24% Pre-market as Earnings Release Delayed, Revenue Recognition Issues

Stock Track
·
25 Feb

Maravai LifeSciences Postpones its Fourth Quarter and Full Year 2024 Earnings Release and Conference Call

GlobeNewswire
·
25 Feb

Maravai Lifesciences Holdings (MRVI) Receives a Buy from Craig-Hallum

TIPRANKS
·
24 Feb

Maravai Lifesciences Completes Acquisition of Officinae Bio's DNA and RNA Business

MT Newswires Live
·
24 Feb

Maravai LifeSciences Completes Acquisition of the DNA and Rna Business of Officinae Bio

THOMSON REUTERS
·
24 Feb

Maravai LifeSciences Completes Acquisition of the DNA and RNA Business of Officinae Bio

Business Wire
·
24 Feb

Wells Fargo Sticks to Its Buy Rating for Maravai Lifesciences Holdings (MRVI)

TIPRANKS
·
10 Feb

Trilink Biotechnologies® and Aldevron Enter Into Non-Exclusive License and Supply Agreement for Cleancap® Mrna Capping Technology

THOMSON REUTERS
·
05 Feb

TriLink BioTechnologies® and Aldevron Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology

Business Wire
·
05 Feb

Craig-Hallum Sticks to Their Buy Rating for Maravai Lifesciences Holdings (MRVI)

TIPRANKS
·
03 Feb

Maravai LifeSciences' TriLink BioTechnologies Partners With Avantor to Expand Nucleic Acid Product Availability in EMEA

MT Newswires Live
·
03 Feb

Avantor, TriLink BioTechnologies partner on nucleic acid solutions in Europe

TIPRANKS
·
03 Feb

TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe

Business Wire
·
03 Feb

Maravai Lifesciences Acquires Molecular Assemblies' Intellectual Property, Related Assets

MT Newswires Live
·
29 Jan

Marvai LifeSciences Buys Assets, IP From Molecular Assemblies

Dow Jones
·
29 Jan

Maravai LifeSciences Acquires Assets and Intellectual Property From Molecular Assemblies

THOMSON REUTERS
·
29 Jan